Trauma-Induced Linear Scleroderma

Cutis

Volumn 63, Issue 1, 1999, Pages 29-32

  Yamanaka, Corrynne T ^a   Gibbs, Neil F ^a  

^a Space and Naval Warfare Systems Center Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL MUSCLE RELAXANT; PHENYTOIN;

ADULT; ARM; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; INJURY; LOCALIZED SCLERODERMA; MALE; PATHOLOGY; REVIEW; WRIST;

ADULT; ARM; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; PHENYTOIN; SCLERODERMA, LOCALIZED; WOUNDS AND INJURIES; WRIST;

EID: 0032619257     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Christianson HB, Dorsey CS, O'Leary PA, et al: Localized scleroderma: a clinical study of two hundred thirty-five cases. Arch Dermatol 74: 629-639, 1956.
2. Falanga V, Medsger TA, Reichlin M, et al: Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104: 849-857, 1986.
3. Winkelmann RK: Localized cutaneous scleroderma. Semin Dermatol 4: 90-103, 1985.
4. Lever WF, Schaumberg-Lever G: Scleroderma. In, Histopathology of the Skin, 7th ed, pp 511-522. Philadelphia, JB Lippincott, 1990.
5. Fan W, Leonardi CL, Penneys NS: Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J Am Acad Dermatol 33: 682-684, 1995.
6. Dillon WI, Saed GM, Fivenson DP: Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosis et atrophicus of patients from North America. J Am Acad Dermatol 33: 617-620, 1995.
7. Wienecke R, Schlupen EM, Zochling N, et al: No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol 104: 23-26, 1995.
8. Buechner SA, Winkelmann RK, Lautenschlager S, et al: Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic, and immunohistochemical observations. J Am Acad Dermatol 29: 190-196, 1993.
9. Neill SM, Nicholl JJ, Hanham IWF, et al: Localized morphea at site of previous radiotherapy. Br J Dermatol 118(Suppl): 110-111, 1988.
10. Colver GB, Rodger A, Mortimer PS, et al: Post-irradiation morphea. Br J Dermatol 120: 831-835, 1989.
11. Trattner A, Figer A, David M, et al: Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 68: 2131-2133, 1991.
12. Mork NJ: Clinical and histopathologic morphea with immunological evidence of lupus erythematosus: a case report. Acta Derm Venerol (Stockh) 61: 367-368, 1981.
13. Singh J, Beck GA: Morphea following chicken pox. Br J Dermatol 93(Suppl): 4344, 1975.
14. McColl G, Buchanan RRC: Unilateral scleroderma following ischemic hand injury. J Rheumatol 21(2): 380-381, 1994.
15. Sire DJ: Proceedings: morphea (linear). Arch Dermatol 110(3): 475, 1974.
16. Ahn JG, Kim YT, Lee CW: Trauma-induced isomorphic lesions in morphea-a brief case report. J Korean Med Sci 10(2): 152-154, 1995.
17. Young EM Jr, Barr RJ: Sclerosing dermatoses. J Cutan Pathol 12(5): 426441, 1985.
18. Falanga V: Localized scleroderma. Med Clin North Am 73(5): 1143-1156, 1989.
19. Schmidt JA, Mizel SB, Cohen D, et al: Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128: 2177-2182, 1982.
20. Ihn H, Sato S, Fujimoto M, et al: Demonstration of interleukin-2, interleukin-4, and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 287: 187-193, 1995.
21. Ihn H, Sato S, Fujimoto M, et al: Demonstration of interleukin 8 in serum samples of patients with localized scleroderma (letter). Arch Dermatol 130: 1327-1328, 1994.
22. Fleischmajer R, Perlish JS: Capillary alterations in scleroderma. J Am Acad Dermatol 2: 161-170, 1980.
23. Moschella SL, Hurley HJ: Connective Tissue Diseases. In, Dermatology, 3rd ed (Sontheimer RD, Euwer RL, eds), pp 1233-1255. Philadelphia, WB Saunders, 1992.
24. Smith EA, LeRoy EC: A possible role for transforming growth factor-ß in systemic sclerosis. J Invest Dermatol 95: 125S-127S, 1990.
25. Murrell DF: A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28: 78-85, 1993.
26. Littman BJ: Linear scleroderma: a response to neurologic injury? Report and literature review. J Rheumatol 16: 1135-1140, 1989.
27. Morgan RJ: Scleroderma: treatment with diphenyihydantoin. Cutis 8: 278-282, 1971.
28. Neldner KH: Treatment of localized linear scleroderma with phenytoin. Cutis 22: 569-572, 1978.
29. Champion RH, Burton JL, Ebling FJG: The Connective Tissue Diseases. In, Textbook of Dermatology, 5th ed (Rowell NR, Goodfield MJD, eds), pp 2225-2245. Oxford, Blackwell, 1992.
30. Joly P, Bamberger N, Crickx B, et al: Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 130: 663-664, 1994.
31. Falanga V, Medsger TAJR: D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 126: 609-612, 1990.
32. Hulshof MM, Pavel S, Breedveld FC, et al: Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 130: 1290-1293, 1994.
33. Humbert P, Aubin F, Dupond JL, et al: Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma, Arch Dermatol 131(7): 850-851, 1995.
34. Kerscher M, Volkenandt M, Meurer M, et al: Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet 343(8907): 1233, 1994.
35. Kerscher M, Meurer M, Sander C, et al: PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 132(11): 1280-1282, 1996.
36. Kerscher M, Dirschka T, Volkenandt M: Treatment of localized scleroderma by UVA1 phototherapy. Lancet 346(8983): 1166, 1995.